This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "Tom Connors" research scientist – news · newspapers · books · scholar · JSTOR (July 2015) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: "Tom Connors" research scientist – news · newspapers · books · scholar · JSTOR (July 2015) (Learn how and when to remove this message) (Learn how and when to remove this message)

Professor Thomas Anthony Connors (18 December 1934 – 4 February 2002) was a British cancer research scientist.[1]

Connors was for 40 years involved in the development of anti-cancer drugs including cis-platinum and its derivative, carbo-platin,[2] two effective anti-cancer agents. Connors' initial research was under the auspices of mentor and friend Professor Walter Ross at the Chester Beatty Institute where he gained his Doctorate in 1960.[3] In 1976 Connors' career expanded into the field of toxicology and he was appointed Director of the Medical Research Council's toxicology unit. Connors also sat on committees including the Cancer Research Campaign. He formed the Phase I/II Drug Development Committee during this period. Connors also advised overseas institutes and their governments. and was a special advisor to President Gerald Ford. On retirement in 1994 Connors was appointed Honorary Professor at the School of Pharmacy, University of London. Connors was awarded many honours including honorary degrees from several universities, Including Aston (1997)[4] and Dublin Trinity in 2001.[5] He has a research unit named after him at Bradford University.[6]

Tom Connors was an alumnus of Wimbledon College, to which he won a scholarship to study in the 1940s/50's. As well as proving to be an adept academic, he represented the school at rugby where he played wing three-quarter and went on to play many times for the Old Wimbledonians rugby club. He also represented the school and London schools at athletics, being at the time one of the fastest boys over 100 yards in the country. Tom was also an active member of the Old Wimbledonians Association.

References

  1. ^ "Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK", British Journal of Cancer (2003) 89, 437–454. doi:10.1038/sj.bjc.6601106 www.bjcancer.com Published online 29 July 2003
  2. ^ Connors TA, et al. (1972). "New platinum complexes with anti-tumour activity". Chem Biol Interact. 5 (6): 415–24. doi:10.1016/0009-2797(72)90078-6. PMID 4652593.
  3. ^ Connors TA, Jones M, Ross WC, Braddock PD, Khokhar AR, Tobe ML (1972). "New platinum complexes with anti-tumour activity". Chem Biol Interact. 5 (6): 415–24. doi:10.1016/0009-2797(72)90078-6. PMID 4652593.
  4. ^ "Honorary graduates of Aston University". Archived from the original on 22 July 2015. Retrieved 4 August 2015.
  5. ^ Trinity College Dublin (2 July 2015). "Recipients - Honorary Degrees - Registrar : Trinity College Dublin, the University of Dublin, Ireland". Retrieved 4 August 2015.
  6. ^ Bradford University http://www.brad.ac.uk/corpcomms/pressreleases/2003/connors.php
Categories